Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EWTX stock hub

Edgewise Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

EWTXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.8B
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
EWTX
In the news

Latest news · EWTX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.6P50 18.3P75 33.7
Trailing P/En/a
P25 15P50 23.3P75 38.5
ROE-38.1
P25 -106.6P50 -46.9P75 -3.1
ROIC-26.8
P25 -63.1P50 -27.5P75 -0
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All EWTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
USD
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001710072
Company name
Edgewise Therapeutics, Inc.
Country
United States
Country code
US
Cusip
28036F105
Employees
146
Employees Change
36%
Employees Change Percent
32.73
Enterprise value
$3.3B
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2021-03-26
Isin
US28036F1057
Last refreshed
2026-05-10
Market cap
$3.8B
Market cap category
Mid-Cap
Price
$35.32
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
EWTX
Website
https://edgewisetx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-4.63%
FCF yield
-3.92%
P/B ratio
7.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-176M
Net Income Growth Years
0%
Profit Per Employee
$-1.2M
ROA
-25.64
Roa5y
-18.79
ROCE
-40.24
ROE
-38.14
Roe5y
-28.36
ROIC
-26.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

5
MetricValue
Cagr1y
143.4%
Cagr3y
53.83%
Cagr5y
3.85%
EPS Growth Years
0
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
$518.5M
Cash
$499.6M
Current Assets
$509.8M
Current Liabilities
$22.5M
Debt
$3.8M
Debt Equity
$0.01
Equity
$493.2M
Liabilities
$25.3M
Long Term Assets
$8.7M
Long Term Liabilities
$2.8M
Net Cash
$495.8M
Net Cash By Market Cap
$13.05
Net Cash Growth
14.81%
Net Debt Equity
$-1.01
Tangible Book Value
$493.2M
Tangible Book Value Per Share
$4.59
WACC
5.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
22.61
Net Working Capital
$-11.3M
Quick ratio
22.16
Working Capital
$487.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-12.32%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

40
MetricValue
1Y total return
143.25%
200-day SMA
23.14
3Y total return
264.12%
50-day SMA
31.6
50-day SMA vs 200-day SMA
50over200
5Y total return
20.79%
All Time High
40.49
All Time High Change
-12.77%
All Time High Date
2021-03-29
All Time Low
5.12
All Time Low Change
589.84%
All Time Low Date
2023-11-10
ATR
2
Beta
0.25
Beta1y
0.47
Beta2y
2.1
Ch YTD
42.33
High
36.21
High52
39.96
High52 Date
2026-05-05
High52ch
-11.61%
Low
34.67
Low52
12.15
Low52 Date
2025-06-26
Low52ch
190.7%
Ma50ch
11.77%
Premarket Change Percent
-1.46
Premarket Price
$35.06
Premarket Volume
1,598
Price vs 200-day SMA
52.66%
RSI
59.03
RSI Monthly
68.8
RSI Weekly
66.87
Sharpe ratio
1.53x
Sortino ratio
2.96
Total Return
-12.32%
Tr YTD
42.33
Tr1m
8.68%
Tr1w
15.39%
Tr3m
21.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

10
MetricValue
Analyst Count
6
Analyst Count Top
4
Analyst Price Target Top
$43
Analyst Ratings
Buy
Analyst Ratings Top
Buy
Earnings EPS Estimate
$-0.49
Operating Income
$-199.6M
Price target
$39
Price Target Change
$10.42
Price Target Change Top
$21.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
67,884,232%
Float Percent
63.09%
Shares Insiders
0.54%
Shares Institutions
79.18%
Shares Out
107,593,006
Shares Qo Q
1.04%
Shares Yo Y
12.32%
Short Float
14.84%
Short Ratio
12
Short Shares
9.37

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Adjusted FCF
$-183.4M
Average Volume
1,298,337.55x
Bv Per Share
4.59
CAPEX
$-472,000
Ch1m
8.68
Ch1w
15.39
Ch1y
143.3
Ch3m
21.38
Ch3y
264.1
Ch5y
20.79
Ch6m
105.8
Change
-0.73%
Change From Open
-0.08
Close
35.58
Days Gap
-0.65
Depreciation Amortization
2,108,000
Dollar Volume
35,872,793.3
Earnings Date
2026-05-07
Earnings Time
bmo
EBIT
$-199.6M
EBITDA
$-197.5M
EPS
$-1.66
F Score
2
FCF
$-149M
FCF EV Yield
-4.51x
FCF Per Share
$-1.38
Financing CF
206,038,000
Fiscal Year End
December
Founded
2,017
Investing CF
-74,255,000
Ipr
120.8
Iprfo
30.81
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-02-26
Ma150
26.03
Ma150ch
35.67%
Ma20
33.03
Ma20ch
6.92%
Net CF
-16,710,000
Next Earnings Date
2026-08-06
Open
35.35
Optionable
Yes
Position In Range
42.21
Ppne
8,730,000
Pre Close
35.58
Price Date
2026-05-08
Ptbv Ratio
7.71
Relative Volume
0.78x
Share Based Comp
34,408,000
Tr6m
105.83%
Us State
Colorado
Volume
1,015,651
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does EWTX pay a dividend?

Capital-return profile for this ticker.

Performance

EWTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+143.3%
S&P 500 1Y: n/a
3Y total return
+264.1%
S&P 500 3Y: n/a
5Y total return
+20.8%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns EWTX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+79.2%
Float: +63.1% of shares outstanding
Insider ownership
+0.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+14.8%
12.0 days to cover
Y/Y dilution
+12.3%
Negative means the company is buying back shares.
Technical

EWTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
59.0
Neutral momentum band
Price vs 200-day MA
+52.7%
50/200-day relationship not available
Beta (5Y)
0.25
Less volatile than the market
Sharpe ratio
1.53
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About EWTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EWTX stock rating?

Edgewise Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EWTX analysis?

The full report lives at /stocks/EWTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EWTX?

The latest report frames EWTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EWTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.